Table 1 IL-9, IL-21 and IL-23 plasma levels in healthy controls and ESRD patients with and without CMV seropositivity
Parameters | Controls (n = 27) | ESRD (n = 117) | p |
|---|---|---|---|
IL-9 (pg/ml) | 799 ± 2203 | 435 ± 930 | 0.74 |
IL-21 (pg/ml) | 368 ± 751 | 194 ± 213 | 0.61 |
IL-23 (pg/ml) | 2.9 ± 11 | 10 ± 17 | <0.001 |
|  | Controls (n = 27) | CMV-IgG- (n = 49) |  |
IL-9 (pg/ml) | 799 ± 2203 | 336 ± 810 | 0.53 |
IL-21 (pg/ml) | 368 ± 751 | 156 ± 175 | 0.25 |
IL-23 (pg/ml) | 2.9 ± 11 | 5.4 ± 7.8 | 0.002 |
|  | Controls (n = 27) | CMV-IgG+ (n = 68) |  |
IL-9 (pg/ml) | 799 ± 2203 | 506 ± 1007 | 0.31 |
IL-21 (pg/ml) | 368 ± 751 | 221 ± 235 | 0.96 |
IL-23 (pg/ml) | 2.9 ± 11 | 14 ± 20 | <0.0001 |
|  | CMV-IgG- (n = 49) | CMV-IgG+ (n = 68) |  |
IL-9 (pg/ml) | 336 ± 810 | 506 ± 1007 | 0.02 |
IL-21 (pg/ml) | 156 ± 175 | 221 ± 235 | 0.12 |
IL-23 (pg/ml) | 5.4 ± 7.8 | 14 ± 20 | <0.001 |